Zosyn (piperacillin/tazobactam) is compatible with Lactated Ringer’s solution, but only if you’re using the reformulated version that contains EDTA. The original formulation of Zosyn, introduced in 1993, was explicitly incompatible with LR. This distinction matters because both formulations may still be encountered in practice.
Why Formulation Matters
When Zosyn first came to market, its labeling stated clearly that Lactated Ringer’s could not be used as a diluent or admixture. The problem was the calcium ions in LR. Mixing the original Zosyn with calcium-containing solutions caused visible particle formation, making the solution unsafe for infusion.
The manufacturer later reformulated Zosyn by adding two stabilizing ingredients: EDTA (edetate disodium) and sodium citrate. EDTA binds calcium ions and prevents them from interacting with the drug, which eliminated the precipitation issue. This reformulated product is compatible with LR both as a diluent for admixture preparation and for co-administration via Y-site. The FDA-approved labeling confirms this: “ZOSYN containing EDTA is compatible for co-administration via a Y-site intravenous tube with Lactated Ringer’s injection, USP.”
How to Confirm You Have the Right Formulation
Check the product labeling or vial for the presence of EDTA (edetate disodium dihydrate) and sodium citrate in the list of inactive ingredients. If the formulation does not contain EDTA, it is not compatible with Lactated Ringer’s. Most Zosyn products currently on the market are the EDTA-containing reformulation, but verifying before mixing is standard practice.
Compatible Diluents at a Glance
For the EDTA-containing formulation, the approved diluents include:
- 0.9% sodium chloride (normal saline)
- 5% dextrose in water (D5W)
- Lactated Ringer’s solution (EDTA formulation only)
Normal saline and D5W are compatible with all Zosyn formulations, making them the safest default choices when the formulation is uncertain.
Y-Site Compatibility With Aminoglycosides
The EDTA reformulation also expanded Y-site compatibility with certain aminoglycosides, which the original product could not safely be co-administered with. Specifically, the EDTA formulation can be given simultaneously through a Y-site with amikacin and gentamicin at defined concentration ranges, when diluted in normal saline, D5W, or (for amikacin) Lactated Ringer’s.
Tobramycin remains incompatible with Zosyn for simultaneous Y-site infusion regardless of formulation. When aminoglycosides need to be given alongside Zosyn, separate administration is still the general recommendation. Y-site co-administration should only happen under the specific conditions outlined in the product labeling.
Key Precaution
Zosyn should not be mixed with other medications in the same syringe or infusion bottle, as compatibility has not been established for most drug combinations. The compatibility with LR and select aminoglycosides applies strictly to the EDTA-containing formulation and only under the conditions specified in the labeling. If there is any doubt about which formulation is on hand, using normal saline or D5W avoids the question entirely.